HOME › DRUGS › LAZERTINIB
ACTIVE SUBSTANCE / INN

LAZERTINIB

Brand name(s): Lazcluze
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Lazertinib
REGULATORS
EMA
SPONSORS / MAH
Janssen Cilag International NV
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LazcluzeJanssen Cilag International NVAuthorised20/01/2025Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON LAZERTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →